Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclacel Pharmaceuticals

5.61
-0.1910-3.29%
Volume:1.66K
Turnover:9.54K
Market Cap:67.29M
PE:-139.33
High:6.04
Open:5.55
Low:5.44
Close:5.80
Loading ...
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

Form 8-K - Current report
Mar 13, 2023

Major Issues Report

Form 8-K - Current report
Mar 09, 2023

Major Issues Report

Form 8-K - Current report
Mar 08, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2023

Major Issues Report

Form 8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 26, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 06, 2023

Major Issues Report

Form 8-K - Current report
Dec 30, 2022

Major Issues Report

Form 8-K - Current report
Dec 09, 2022

Major Issues Report

Form 8-K - Current report
Nov 10, 2022

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2022

Major Issues Report

Form 8-K - Current report
Oct 31, 2022

Major Issues Report

Form 8-K - Current report
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities